Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases

Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases

Coronavirus disease 2019 (COVID-19) vaccination is essential for patients with autoimmune inflammatory rheumatic diseases (AIIRD) to reduce the risk of morbidity and mortality associated with serious COVID-19 infection. With endemicity, waning of vaccine- and infection-acquired immunity, and develop...

Full description

Bibliographic Details
Main Authors: Ruth Xian Lynn Yap, Yi Wye Lai, Chang Wei, Joel Jia Wei Ng, Dan Xu, Shuo Feng, Rong Mu, Bernard Yu-Hor Thong, Chuanhui Xu
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Vaccines
Subjects:
vaccination
COVID-19
autoimmune inflammatory rheumatic disease
immunogenicity
Online Access:https://www.mdpi.com/2076-393X/12/3/274

Internet

https://www.mdpi.com/2076-393X/12/3/274

Similar Items